Impact of prior ALK-tyrosine kinase inhibitor on pemetrexed-based chemotherapy in patients with advanced ALK positive non-small cell lung cancer.

被引：0
|
作者：
Yabe, Michitoshi
Kenmotsu, Hirotsugu
Kodama, Hiroaki
Nishioka, Naoya
Miyawaki, Eriko
Miyawaki, Taichi
Mamesaya, Nobuaki
Kobayashi, Haruki
Omori, Shota
Wakuda, Kazushige
Ono, Akira
Naito, Tateaki
Murakami, Haruyasu
Takahashi, Toshiaki
机构：
[1] Shizuoka Canc Ctr, Sunto Gun, Japan
[2] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Shizuoka, Japan
[4] Shizuoka Canc Ctr, Div Thorac Oncol, Sunto Gun, Shizuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21113
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
    Shaw, A. T.
    Varghese, A. M.
    Solomon, B. J.
    Costa, D. B.
    Novello, S.
    Mino-Kenudson, M.
    Awad, M. M.
    Engelman, J. A.
    Riely, G. J.
    Monica, V.
    Yeap, B. Y.
    Scagliotti, G. V.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 59 - 66
  • [2] Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK plus Non-Small Cell Lung Cancer
    Jo, Jaemin
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Juhyun
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    Chung, Jin-Haeng
    Jeon, Yoon Kyung
    Lee, Jong Seok
    YONSEI MEDICAL JOURNAL, 2018, 59 (02) : 202 - 210
  • [3] VATS Right Upper Lobectomy for Advanced Non-Small Cell Lung Cancer After ALK-Tyrosine Kinase Inhibitor Administration.
    Yamamoto, K.
    Kuwahara, M.
    Yamamoto, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S666 - S667
  • [4] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] ECONOMIC ANALYSIS OF THE USE OF CRIZOTINIB, A TYROSINE KINASE ALK INHIBITOR, IN THE TREATMENT OF ALK POSITIVE NON-SMALL CELL LUNG CANCER IN THE MEXICAN SETTING
    Gay-Molina, J. G.
    Sanchez-Kobashi, R.
    Mucino-Ortega, E.
    Gutierrez-Coln, C., I
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2012, 15 (07) : A422 - A422
  • [6] Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer
    Imase, R.
    Endo, S.
    Sasahara, Y.
    Shinmura, T.
    Ozawa, T.
    Majima, H.
    Hara, T.
    Shimada, H.
    Yamauchi, S.
    Sakakibara, Y.
    Kobayashi, A.
    Yamazaki, K.
    Jin, Y.
    Yamanaka, K.
    Matsubara, O.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1953 - S1953
  • [7] Crizotinib versus pemetrexed-based chemotherapy in patients with advanced ROS1-rearranged non-small cell lung cancer.
    Shen, Lan
    Lu, Shun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
    Mezquita, L.
    Remon, J.
    Nicotra, C.
    Noerholm, M.
    Brinkmann, K.
    Planchard, D.
    Jovelet, C.
    Auclin, E.
    Flinspach, C.
    Hurley, J.
    Skog, J.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Lacroix, L.
    Auger, N.
    Friboulet, L.
    Soria, J.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1954 - S1955
  • [9] Long-term clinical outcomes of ALK inhibitors in patients with ALK-positive advanced non-small cell lung cancer.
    Murakami, Haruyasu
    Ono, Akira
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Patient and Oncologist Preferences for ALK plus Advanced Non-Small Cell Lung Cancer Tyrosine Kinase Inhibitor Treatments
    Le, H.
    Coulter, J.
    Cappelleri, J. C.
    Lu, H.
    Quaife, M.
    Meginnis, K.
    Fernandez, G.
    Culver, K.
    Vaghela, S.
    Rifi, N.
    Stinchcombe, T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S202 - S202
12345